Pharma Industry
Industry: Email Alert RSS FeedBiota and GlaxoSmithKline finalize hepatitis C agreement. (Markets: Life Sciences).(also mentions Gilead and Ribahparm's hepatitis drugs)(Brief Article)
Chemical Market Reporter, August, 2002
GLAXOSMITHKLINE PLC (GSK) and Biota Holdings Ltd. have finalized a license agreement aimed at developing new drugs for the $2 billion hepatitis C market. For GSK, the deal comes on the heels of a $10 million pact with Gilead Sciences Inc. for hepatitis B drug adefovir dipivoxil, expected to launch in the US by year-end.
Biota's US subsidiary Biota Inc. will receive $3.5 million in payments from GSK over the next two years, as well as milestone payments and royalties on compounds that reach the market.
Biota will synthesize nucleosides and identify novel compounds that GSK will screen against hepatitis C and other viruses. Formerly, Biota partnered with GSK for influenza drug Relenza (zanamivir for inhalation), which competes with Gilead's oral...
Brought to you by CBS MoneyWatch.com
- Best- and Worst-Paid College Degrees
- 6 Things You Should Never Do on Twitter or Facebook
- How Much Sleep Do You Really Need?
- 6 Big Myths about Gas Mileage
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Design a commission plan that drives sales - Sales Commissions
- Using object-oriented analysis and design over traditional structured analysis and design
Presented by American Express